Positive data from Biogen Idec’s AVONEX clinical trial on multiple sclerosis presented at CMSC 2011
Biogen Idec today announced the findings from a randomized, multicenter, dose-blinded clinical trial that evaluated the effect of AVONEX dose titration, or gradual dose escalation, on flu-like symptoms associated with the therapy.